1. Armitage, J. O., Corder, M. P., Leimer, J. T., Dick, F. R., Eliiott, T. F.: Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) without maintenance therapy. Cancer Treat. Rep. 64, 649–654 (1980).
2. Arnold, A. M.: Podophyllotoxin derivative VP 16-213. Cancer Chemother. Pharmacol. 3, 71–80 (1979).
3. Bender, R. A., Anderson, T., Fischer, R. T., et al.: The activity of the epipodophyllotoxin VP16 in the treatment of combination chemotherapy resistant non-Hodgkin’s lymphoma. Amer. J. Hematol. 5, 203–209 (1978).
4. Bender, R. A., DeVita, V. T., jr.: Non-Hodgkin’s lymphoma. In: Randomized Trials in Cancer, a Critical Review by Sites (Staquet, M.J., (Hrsg.), S. 77. New York: Raven Press. 1978.
5. Cabanillas, F., Rodriguez, V., Bodey, G. P.: Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphoma. Cancer Treat. Rep. 64, 933–937 (1980).